Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of anakinra in treatment of COVID-19
IRCT20120703010178N20Phase 3Completed
- Sponsor
- PersisGen
- Start
- Jun 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of anakinra in coronavirus disease 2019 (COVID-19), sponsored by PersisGen. Started Jun 2020; status: completed.
02
Drugs
anakinra
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20120703010178N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120703010178N20.